Stay updated on Gantenerumab Long-term Safety in AD Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab Long-term Safety in AD Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s footer revision/version has been updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a site release rather than a change to the clinical study details.
    Difference
    0.0%
    Check dated 2026-04-26T09:27:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T01:56:47.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T08:38:07.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T19:13:20.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The site shows a revision update from v3.4.1 to v3.4.2. No changes to core study details or navigation are observed.
    Difference
    0.0%
    Check dated 2026-02-13T12:13:08.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new revision tag (v3.4.1) was added and the previous revision (v3.4.0) removed; there are no changes to the study content or visible page information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:16:56.000Z thumbnail image

Stay in the know with updates to Gantenerumab Long-term Safety in AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab Long-term Safety in AD Clinical Trial page.